Use of diffusion-weighted MRI and neurological deficit scores to demonstrate beneficial effects of isradipine in a rat model of focal ischemia

Pharmacology

Volumn 58, Issue 6, 1999, Pages 292-299

  Chandra, Sudeep ^a   White, Ray F ^a   Everding, Daryl ^a   Feuerstein, Giora Z ^a   Coatney, Robert W ^a   Sarkar, Susanta K ^a   Barone, Frank C ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Diffusion weighted MRI; Ischemic brain injury; Ischemic stroke; Isradipine; Middle cerebral artery; Neurological deficits; Neuroprotection; Occlusion

Indexed keywords

ISRADIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HISTOLOGY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BRAIN ISCHEMIA; CALCIUM CHANNEL BLOCKERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, SUBCUTANEOUS; ISRADIPINE; MAGNETIC RESONANCE IMAGING; MALE; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS; RATS; RATS, INBRED SHR;

EID: 0032966764     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028294     Document Type: Article

References (21)

1. Ruegg UT: Pharmacology of the calcium antagonist isradipine. Drugs 1990;40(suppl 2):3-9.
2. Sauter A, Rudin M: Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resoncance imaging. Stroke 1986;17:1228-1234.
3. Sauter A, Rudin M: Treatment of hypertension with isradipine reduces the infarct size following stroke in experimental animals. Am J Med 1989;86(suppl 4A):130-133.
4. Welzel D, Burger KJ: The calcium antagonist isradipine in the therapy of hypertension: A double-blind crossover comparison with nifedipine. Drugs 1990;40(suppl 2):60-64.
5. Sauter A, Rudin M: Experimental studies with isradipine in stroke. Drugs 1990;40(suppl 2):44-51.
6. 2-weighted MRI and spectroscopy. Magn Reson Med 1990;14:330-346.
7. Minematsu K, Li L, Fisher M, Sotak CH, Davis MA, Fiandaca MS: Diffusion-weighted magnetic resonance imaging: Rapid and quantitative detection of focal brain ischemia. Neurology 1992;42:235-240.
8. Minematsu K, Fisher M, Li L, Davis MA, Knapp AG, Cotter RE, McBurney RN, Sotak CH: Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weighted MRI. Neurology 1993;43:397-403.
9. Tatlisumak T, Carano RAD, Takano K, Opgenorth TJ, Sotak CH, Fisher M: A novel endothelin antagonist, A-127722, attenuates ischemic lesion size in rats with temporary middle cerebral artery occlusion: A diffusion and perfusion MRI study. Stroke 1998;29:850-858.
10. Barone FC, Price WJ, White RF, Willette RN, Feuerstein GZ: Genetic hypertension and increased susceptibility to cerebral ischemia. Neurosci Biobehav Rev 1992;16: 219-233.
11. Barone FC, Arvin B, White RF, Miller A, Willette RN, Lysko PG, Feuerstein GZ: Tumor necrosis factor α: A mediator of focal ischemic brain injury. Stroke 1997;28:1233-1244.
12. Barone FC, Clark RK, Price WJ, White RF, Storer BL, Feuerstein GZ, Ohlstein EH: Neuron specific enolase increases in cerebral and systemic circulation following focal ischemia. Brain Res 1993;623:77-82.
13. Bederson JB, Pitts LH, Nishimura MC, Davis RL, Bartowski H: Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurological examination. Stroke 1986;17:472-476.
14. Bederson JB, Pitts LH, German SM, Nishimura MC, Davis RL, Bartkowski HM: Evaluation of 2,3,5-tetraphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986;17:1304-1308.
15. Winer BJ: Statistical Principles in Experimental Design. New York, McGraw-Hill, 1971.
16. Rogers DC, Cambell CA, Stretton JL, MacKay KB: Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke 1997;28: 2060-2066.
17. Barone FC, Price WJ, Jacobsen P, Sheardown MJ, Feuerstein GZ: Pharmacologic profile of a novel neuronal calcium channel blocker includes reduced cerebral damage and neurological deficits in rat focal ischemia. Pharmacol Biochem Behav 1991;48:77-85.
18. Barone FC, Lysko PG, Price WJ, Feuerstein GZ, Al-Baracanji KA, Benham CD, Harrison DC, Harries MH, Bailey ST, Hunter AJ: SB 201823-A antagonizes calcium currents in central neurons and reduces the effects of focal ischemia in rats and mice. Stroke 1995;26:1683-1690.
19. Clark RK, Lee EV, Fish CJ, White RF, Price WJ, Jonak ZL, Feuerstein GZ, Barone FC: Progression of cerebral changes following middle cerebral artery occlusion in the rat: A quantitative planimetric, histologic and immunohistochemical study. Brain Res Bull 1993;31:565-572.
20. Barone FC, Clark RK, Feuerstein G, Lenkinski RE, Sarkar SK: Quantitative comparison of magnetic resonance imaging (MRI) and histologic analyses of focal ischemic damage in the rat. Brain Res Bull 1991;26:285-291.
21. Verheul HB, Balazs R, Berkelbach van der Sprenkel JW, Tulleken CA, Nicolay K, Tamminga KS, van Lookeren Campagne MN: Comparison of diffusion-weighted MRI with changes in cell volume in a rat model of brain injury. NMR Biomed 1994;7:96-100.